Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Dosing”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Post-approval studies (Phase 4)Study completedNCT00241124
What this trial is testing

Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes

Who this might be right for
Hypertension
Novartis 1,099
Early research (Phase 1)Study completedNCT03392961
What this trial is testing

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Who this might be right for
Type 2 Diabetes Mellitus
Biocon Limited 51
Post-approval studies (Phase 4)Ended earlyNCT02680054
What this trial is testing

Additional Insulin for Fat and Protein in Children With Diabetes Study

Who this might be right for
Type 1 Diabetes
Oxford University Hospitals NHS Trust 38
Not applicableStudy completedNCT02542631
What this trial is testing

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Calibra Medical, Inc. 278
Testing effectiveness (Phase 2)Study completedNCT01629251
What this trial is testing

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing

Who this might be right for
Type 1 Diabetes
University of Cambridge 8
Testing effectiveness (Phase 2)Study completedNCT02714972
What this trial is testing

Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents

Who this might be right for
Type 1 DiabetesHypoglycemiaHyperglycemia+1 more
Jaeb Center for Health Research 35
Not applicableStudy completedNCT01819844
What this trial is testing

Inpatient Closed-loop Glucose Control

Who this might be right for
Diabetes MellitusHyperglycemia
Massachusetts General Hospital 12
Not applicableUnknownNCT05924932
What this trial is testing

Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

Who this might be right for
Diabetes Mellitus, Type 1
Masaryk Hospital Usti nad Labem 120
Not applicableLooking for participantsNCT07304778
What this trial is testing

Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol

Who this might be right for
Diabetes (Insulin-requiring, Type 1 or Type 2)
Universidad Complutense de Madrid 34
Not applicableStudy completedNCT04878120
What this trial is testing

Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Virginia 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT06600776
What this trial is testing

Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System

Who this might be right for
Type 1 Diabetes (T1D)
Tel-Aviv Sourasky Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01365507
What this trial is testing

Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 276
Not applicableStudy completedNCT06206525
What this trial is testing

Feasibility Trial Using an Inpatient Insulin Dosing Calculator

Who this might be right for
Diabetes Mellitus, Type 2
University of Washington 38
Post-approval studies (Phase 4)Study completedNCT04533646
What this trial is testing

Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes

Who this might be right for
Cystic Fibrosis-related Diabetes
Jagdeesh Ullal 13
Testing effectiveness (Phase 2)Study completedNCT01697618
What this trial is testing

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 13
Post-approval studies (Phase 4)UnknownNCT02361489
What this trial is testing

Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices

Who this might be right for
Diabetes Type II
Valeritas, Inc. 90
Early research (Phase 1)Ended earlyNCT02588950
What this trial is testing

U-500 Insulin (LY041001) in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 11
Early research (Phase 1)Study completedNCT01444677
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers

Who this might be right for
Metabolic SyndromeObesity
Yungjin Pharm. Co., Ltd. 40
Not applicableStudy completedNCT01377155
What this trial is testing

A Comparison of Two Initial Dosing Formulas

Who this might be right for
Diabetes Mellitus, Type 2
Diabetes Care Center 20
Post-approval studies (Phase 4)Study completedNCT04849845
What this trial is testing

Afrezza® Dosing Optimization Study

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Mannkind Corporation 20
Load More Results